Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Issue of Equity

16 May 2006 11:56

Mercury Group PLC16 May 2006 MERCURY GROUP PLC ("Mercury" or "the Company") Issue of Shares Mercury announces the issue and allotment of a total of 6,481,049 new OrdinaryShares of 1.0p each in the share capital of the Company to the vendors ofNavitas Hemway Limited (including certain Directors of Mercury), representingthe final payment of the deferred purchase price as agreed at the time ofacquisition in December 2005. The issue price of the new Ordinary Shares is9.166p per share, representing the average closing price per share on the firstand last Friday of each of the three months prior to the date of allotment. Thedeferred consideration has an aggregate value equal to the net profit of NavitasHemway Limited for the year ended 30 September 2005 and has been calculated inaccordance with the terms of the Navitas Hemway Sale & Purchase Agreement dated3 December 2004, as referred to in the Company's announcement of 3 December2004, details of which were included in the Company's AIM Admission Document ofthe same date. The acquisition of Navitas Hemway was approved by shareholders on29 December 2004. As a result, the beneficial interests of certain Directors have increased as follows: Former Former holding Shares issued Revised Holding as % of holding as % of former as consideration Holding current issued issued share for Navitas share capital capital Hemway David J Williams (Note 1) 4,599,365 4.32% 1,127,119 5,726,484 5.07%Anthony McFarland (Note 2) 2,540,591 2.39% 2,879,855 5,420,374 4.80% These new Ordinary Shares will rank pari passu in all respects with the existingshare capital in the Company. This issue of shares takes the revised number ofshares in issue to 112,975,684. Application has been made for the new OrdinaryShares to be admitted to trading on AIM. It is anticipated that Admission willbecome effective on 19 May 2006. Note 1: Mr Williams' holding is registered in his own name. Note 2: 189,000 of these Ordinary Shares are registered in the name of JTMHoldings Limited, 360,000 are registered in the name of Malvay Limited, and1,800,591 are registered in the name of Paradene Limited. Paradene Limited is the allottee of the 2,879,855 ordinary shares newly issuedby way of deferred consideration for the acquisition of Navitas Hemway. Mr AMcFarland is the sole beneficial owner of Paradene Limited and has a beneficialinterest of 23.78 per cent. in JTM Holdings and Malvay Limited is a wholly ownedsubsidiary of JTM Holdings Limited. Holdings registered in the names of JTM Holdings Limited and Malvay Limited havebeen treated as part of Mr McFarland's notifiable interest in their entirety. The balance of 191,000 Ordinary Shares beneficially held by Mr A McFarland isregistered in his own name. Enquiries : Simon H Michaels Mercury Group plc 020 7422 6585Finance Director Katie Tzouliadis Biddicks 020 7448 1000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th May 20213:27 pmRNSDirector/PDMR Shareholding
28th May 20212:43 pmRNSDirector/PDMR Shareholding
25th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
11th May 20217:10 amRNSNon-Executive Director Change
11th May 20217:10 amRNSResults for the year ended 31 December 2020
20th Apr 20219:30 amRNSHolding(s) in Company
16th Apr 20219:47 amRNSHolding(s) in Company
29th Mar 202110:48 amRNSHolding(s) in Company
25th Mar 20218:05 amRNSCompletion of Acquisition & Director/PDMR Dealings
23rd Mar 20219:31 amRNSCorrection: Results of Fundraise and TVR
23rd Mar 20217:00 amRNSResults of Fundraise and Total Voting Rights
23rd Mar 20217:00 amRNSRe-release: Proposed acquisition of US-based RadMD
22nd Mar 20215:07 pmRNSProposed Fundraise to raise approximately £16m
22nd Mar 20215:07 pmRNSProposed acquisition of US-based RadMD
19th Mar 20217:00 amRNSMicrosoft Research’s Dr Junaid Bajwa joins as NED
22nd Feb 20217:00 amRNSMedica and Integral Diagnostics establish JV, MedX
11th Feb 202110:09 amRNSHolding(s) in Company
29th Jan 20219:02 amRNSHolding(s) in Company
26th Jan 20217:00 amRNSAppointment of Liberum as Joint Corporate Broker
21st Jan 20217:00 amRNSTrading Update
18th Jan 20217:00 amRNSDr. Robert Lavis appointed Group Medical Director
4th Dec 202011:57 amRNSDirector/PDMR Shareholding
2nd Dec 20209:31 amRNSDirector/PDMR Shareholding
1st Dec 20209:34 amRNSHolding(s) in Company
18th Nov 20204:41 pmRNSSecond Price Monitoring Extn
18th Nov 20204:36 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSDirector/PDMR Shareholding
11th Nov 202012:41 pmRNSHolding(s) in Company
10th Nov 20201:56 pmRNSHolding(s) in Company
6th Nov 20202:26 pmRNSHolding(s) in Company
5th Nov 20207:00 amRNSDirector/PDMR Shareholding
4th Nov 20207:00 amRNSMedica acquires Global Diagnostics Ireland
27th Oct 20209:20 amRNSHolding(s) in Company
22nd Oct 20209:41 amRNSHolding(s) in Company
16th Oct 202011:26 amRNSHolding(s) in Company
7th Oct 202012:34 pmRNSHolding(s) in Company
16th Sep 20201:07 pmRNSDeclaration of Dividend
14th Sep 20207:00 amRNSInterim results demonstrate resilient performance
9th Sep 202010:36 amRNSHolding(s) in Company
25th Aug 20204:41 pmRNSSecond Price Monitoring Extn
25th Aug 20204:36 pmRNSPrice Monitoring Extension
14th Aug 20209:56 amRNSHolding(s) in Company
21st Jul 202010:49 amRNSHolding(s) in Company
8th Jul 20207:00 amRNSTrading Update
11th Jun 20203:22 pmRNSDirector/PDMR Shareholding
1st Jun 20204:54 pmRNSIssue of Equity
28th May 202010:14 amRNSHolding(s) in Company
21st May 202012:55 pmRNSHolding(s) in Company
20th May 20204:25 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.